AIAxios1h ago
Altis Labs, whose AI model analyzes CT scans taken during oncology
Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, has raised a $25M Series A
TL;DRAI startup Altis Labs raised $25M to predict cancer patient survival from CT scans in drug trials.
Why it matters: Faster survival predictions could accelerate oncology drug development and improve trial efficiency for pharma companies.
Altis Labs, an AI software company for drug development, raised a $25 million Series A, CEO Felix Baldauf-Lenschen tells Axios Pro.
Read full articleSource: Axios · Opens in new tab